Download PDF
Case Studies > Harnessing AI to create next-generation medicines

Harnessing AI to create next-generation medicines

Technology Category
  • Analytics & Modeling - Machine Learning
  • Application Infrastructure & Middleware - Data Exchange & Integration
Applicable Industries
  • Healthcare & Hospitals
  • Life Sciences
Applicable Functions
  • Product Research & Development
  • Quality Assurance
Use Cases
  • Predictive Quality Analytics
Services
  • Data Science Services
The Challenge
Absci, a drug and target discovery company, was facing several challenges in its operations. The success of their work heavily relied on coordination across teams. However, they were managing sample handoffs in spreadsheets, which not only had the risk of error but also lacked sophisticated collaboration features, making it difficult to share and reference data. Additionally, the performance of their AI models depended on the quality of the training data. They occasionally experienced data-related deviations such as duplicate or incomplete datasets and risked copy/paste errors. Lastly, they lacked a universally accessible tool for data connectivity, making it difficult for stakeholders to drive organizational and scientific decisions.
About The Customer
Absci is a drug and target discovery company that harnesses deep learning AI and synthetic biology to expand the therapeutic potential of proteins. Through its Integrated Drug Creation™ Platform, Absci is able to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with Absci to create the next generation of protein-based drugs. The company is based in Vancouver, Washington, US, and has between 51 to 250 employees. They operate in the Biotechnology Research industry.
The Solution
Absci adopted Benchling to address their challenges. Benchling provided a formal request handoff data model that tracks sample handoffs and makes it possible to manage data in a way that is machine readable. This resulted in substantially improved operational efficiency in the laboratory. Benchling’s unique data model flexibility, API, and data warehouse capabilities allowed Absci to develop critical applications in the Benchling platform that enabled seamless integration with its distributed data model and application ecosystem. Absci uses Benchling’s custom registry schema to connect disparate data types, manage metadata associations, store experiment outcomes, and link to large quantities of raw data that they use to train AI models.
Operational Impact
  • Improved quality of data capture
  • Increased throughput across their screening funnel
  • Improved data accessibility and interoperability between teams

Related Case Studies.

Contact us

Let's talk!

* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.